Dance and movement programs during and after breast cancer

Evidence label: Promising symptom evidence with program heterogeneity · Clinical goal: reduce fatigue, sleep disturbance or depression and support quality of life

Evidence at a glance

A randomized trial of 176 women receiving chemotherapy for breast cancer compared a 16-week dance program with educational consultation and reported better symptom-cluster and quality-of-life outcomes.
A 2024 review of 16 studies involving 893 participants found inconsistent results and substantial risk of bias; pooled quality-of-life effects for dance/movement therapy were not clearly positive.
These programs are supportive care, not evidence that dance changes tumor response, recurrence or survival.

What was studied

The chemotherapy trial used a structured 16-week program and evaluated fatigue, sleep disturbance and depression as a symptom cluster. Reported between-group results favored dance for the cluster (P=.003) and quality of life (P=.001). The active ingredients may include physical activity, music, group support, attention and mastery, not movement alone.

The broader review separated dance/movement therapy from other dance interventions. Across 16 studies, small samples, different comparators and high risk of bias reduced confidence. For dance/movement therapy, the pooled quality-of-life estimate did not show a clear benefit; some depression and fatigue signals appeared in other dance formats.

Safety and practical context

Programs should be adapted for falls risk, neuropathy, anemia, cardiopulmonary disease, lymphedema, recent surgery and bone metastases. Fever, chest pain, new neurologic symptoms or sudden focal bone pain warrant medical evaluation, not exercise progression.

A seated, home-based or rehabilitation-supervised format may preserve the social and expressive elements while reducing risk.

Bottom line

Dance can be an engaging way to move and connect, and one good-sized trial is encouraging. The total evidence remains heterogeneous, so preference and safe adaptation should guide use.

Questions for the care team

Do I need rehabilitation or oncology clearance because of neuropathy, balance problems or bone disease?
Is the program an appropriate intensity during my chemotherapy cycle?
What symptom or functional measure will tell us whether it is helping?

Sources

Literature searched: October 23, 2026 · Record appraised: October 23, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.